Adobe
ADBE
Lennar Corp
LEN
Petroleo Brasileiro SA Petrobras
PBR
Apple
AAPL
D.R. Horton
DHI
US Stock MarketDetailed Quotes
PFE Pfizer
- 26.560
- -0.180-0.67%
Close Dec 26 16:00 ET
- 26.540
- -0.020-0.08%
Post 20:01 ET
150.52BMarket Cap35.41P/E (TTM)
26.720High26.480Low31.51MVolume26.640Open26.740Pre Close837.66MTurnover0.56%Turnover Ratio71.78P/E (Static)5.67BShares31.05752wk High1.63P/B150.29BFloat Cap24.10552wk Low1.67Dividend TTM5.66BShs Float53.878Historical High6.29%Div YieldTTM0.90%Amplitude5.393Historical Low26.580Avg Price1Lot Size
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Profile
SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees88000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com
Company Executives
- Name
- Position
- Salary
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 21.56M
- Michael McDermott
- Executive Vice President and Chief Global Supply Officer
- --
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Aamir Malik
- Chief Commercial Officer, U.S. and Executive Vice President
- 5.42M
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 5.28M
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Dr. Chris Boshoff, M.D.,PhD
- Executive Vice President and Chief Oncology Officer
- --
- Dr. Mikael Dolsten, M.D.,PhD
- Chief Scientific Officer and President, Pfizer Research and Development
- 8.86M
- Lidia L. Fonseca
- Chief Digital and Technology Officer and Executive Vice President
- --
- Rady A. Johnson
- Chief Compliance, Quality and Risk Officer and Executive Vice President
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Douglas M. Lankler
- Executive Vice President and General Counsel
- 5.48M
- Mortimer J. Buckley
- Director
- --
- Cyrus Taraporevala
- Director
- --
- Ronald E. Blaylock
- Independent Director
- 380.00K
- James C. Smith
- Independent Director
- 390.00K
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 410.00K
- Shantanu Narayen
- Lead Independent Director
- 430.00K
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 391.40K
- James Robert Quincey
- Independent Director
- 380.00K
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 363.00K
- Suzanne Nora Johnson
- Independent Director
- 410.00K
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 417.20K
- Joseph J. Echevarria
- Independent Director
- 390.00K
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 360.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
